ArticleAmerican journal of translational research2025
Efficacy of minimally invasive small-incision-assisted reduction with percutaneous Kirschner wire fixation in pediatric supracondylar humerus fractures.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Arthroscopy-assisted reduction for Jacob type II pediatric humeral lateral condyle fractures: a clinical efficacy study.Frontiers in pediatrics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo retrospectively evaluate whether minimally invasive small-incision-assisted reduction with percutaneous Kirschner wire fixation (MIAR-PKWF) provides superior clinical outcomes compared to conventional closed reduction with Kirschner wire fixation (CR-KWF) in pediatric supracondylar humerus fractures (SCHFs), focusing on surgical outcomes, postoperative recovery, and elbow joint function.
methodsA total of 100 pediatric SCHF cases were included and divided into either an observation group (MIAR-PKWF, n=55) or a control group (standard CR-KWF, n=45) based on their treatment approach. Outcome measures included operative time, recovery indicators, radiographic and serological parameters, elbow joint function, elbow range of motion, complications, and post-reduction swelling.
resultsIn comparison with the control group, the observation group exhibited significantly improved surgical outcomes, accelerated rehabilitation, and better elbow joint function and mobility, radiographic indices, and serological markers. Additionally, the observation group experienced fewer complications and milder post-reduction swelling.
conclusionMIAR-PKWF is more effective in optimizing surgical outcomes, expediting postoperative rehabilitation, and improving elbow function in pediatric SCHF patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.